Related Experiment Video

Updated: Aug 10, 2026

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
11:06

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells

Published on: February 24, 2014

[P53 mutations, asset or disadvantage for cancer chemotherapy]

A Jacquemin-Sablon1

  • 1Unité de biochimie-enzymologie, URA 147 CNRS, Institut Gustave-Roussy, Villejuif.

Bulletin Du Cancer
|July 1, 1997
PubMed

Insights

The p53 protein, or "guardian of the genome," stops cell division after DNA damage. Mutations in p53 found in many tumors significantly alter tumor cell sensitivity to chemotherapy drugs.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Biology

Context:

  • The p53 protein acts as a critical regulator in cellular responses to DNA damage and cytotoxic agents.
  • p53 function is essential for preventing cell division and inducing apoptosis upon DNA damage.
  • Mutations in the p53 gene are prevalent in approximately 50% of human cancers, leading to altered protein functions.

Purpose:

  • To investigate the functional consequences of p53 alterations in human tumors.
  • To analyze how p53 mutations impact tumor cell sensitivity to chemotherapy.
  • To understand the role of the p53 protein in cancer treatment resistance.

Summary:

  • This study examines the effects of mutations in the p53 protein, known as the "guardian of the genome," on cancer cells.
  • p53 normally halts cell cycle progression at the G1/S transition or induces apoptosis in response to DNA damage.
  • The research discusses how alterations in p53 properties, due to mutations in cancer, influence the effectiveness of chemotherapy.

Impact:

  • Provides insights into the mechanisms of chemotherapy resistance in tumors with p53 mutations.
  • Highlights the importance of p53 status in predicting patient response to cancer therapy.
  • Informs the development of targeted therapeutic strategies for p53-mutated cancers.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...